Evaluation of the Immunopharmacology of EDP1815 and EDP2939

Clinical trial NCT05682222 · COMPLETED

Trial details

NCT number: NCT05682222
Sponsor: Evelo Biosciences, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

KLH and Imiquimod Induced Skin Inflammation in Healthy Volunteers

Start date: 2022-06-27
Primary completion: 2022-10-14
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.